clofibrate has been researched along with inositol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Schwartzkopff, W; Zschiedrich, M | 2 |
| Falkensammer, C; Fischer, M | 1 |
| Pistautz, H | 1 |
| Bolzano, K; Haslauer, F; Krempler, F | 1 |
| el Eisch, IA; Paltauf, F; Pristautz, H | 1 |
| Frahm, H; Wilke, H | 2 |
| Kluthe, R; Schäfer, B | 1 |
| Haase, W; Kluthe, R; Schäfer, B | 1 |
| Rahlfs, VW | 1 |
| Fenster, R | 1 |
| Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 3 |
6 trial(s) available for clofibrate and inositol
| Article | Year |
|---|---|
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Topics: Cholestanol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperlipidemias; Inositol; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Nicotinyl Alcohol; Triglycerides | 1978 |
[New drug combination for medical management of hyperlipemia: clinical study].
Topics: Aged; Blood Glucose; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Drug Combinations; Humans; Hyperlipidemias; Hypolipidemic Agents; Inositol; Middle Aged; Nicotinic Acids; Time Factors; Triglycerides | 1977 |
[The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Inositol; Male; Middle Aged; Nicotinic Acids | 1975 |
[The lipid-reducing efficiency of a clofibrate-inositolnicotinate combination in comparison with clofibrate. The wrong use of statistical methods--presented on an example from clinical research].
Topics: Clinical Trials as Topic; Clofibrate; Drug Combinations; Humans; Inositol; Lipid Metabolism; Lipids; Medication Errors; Nicotinic Acids; Statistics as Topic | 1975 |
[Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Inositol; Male; Nicotinic Acids; Triglycerides | 1976 |
[The management of hyperlipoproteinemia with Liproreduct].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Inositol; Male; Middle Aged; Nicotinic Acids; Placebos; Time Factors | 1974 |
12 other study(ies) available for clofibrate and inositol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Topics: Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Inositol; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids | 1976 |
[Clinical study with a new antihyperlipemic combination].
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clofibrate; Drug Combinations; Female; Hemostasis; Humans; Hyperlipidemias; Inositol; Liver; Male; Middle Aged; Nicotinic Acids; Phospholipids; Triglycerides; Uric Acid | 1977 |
[Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Drug Combinations; Female; Humans; Hyperlipoproteinemias; Inositol; Lipids; Male; Middle Aged; Nicotinic Acids; Triglycerides | 1979 |
[Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].
Topics: Adult; Aged; Biopharmaceutics; Clofibrate; Drug Combinations; Humans; Inositol; Male; Middle Aged; Nicotinic Acids | 1977 |
[Letter: Clofibrate and clofibrate-inositolnicotinate].
Topics: Clofibrate; Drug Combinations; Inositol; Nicotinic Acids | 1976 |
[Letter: Clofibrate and clofibrate-inositolnicotinate].
Topics: Clofibrate; Drug Combinations; Hyperlipidemias; Inositol; Nicotinic Acids | 1976 |
[Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Topics: Clofibrate; Drug Combinations; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids | 1983 |
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Topics: Adolescent; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicotinic Acids; Nicotinyl Alcohol; Xanthinol Niacinate | 1980 |
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Inositol; Lipoproteins; Nicotinic Acids; Xanthinol Niacinate | 1980 |